Robert Haddad
www.mendeley.com
0000-0003-1413-0079
2 papers found
Refreshing results…
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651
Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations
Missing publications? Search for publications with a matching author name.